Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Misoprostol for Cervical Priming in Diagnostic Hysteroscopy
NCT03638856Completed
- Sponsor
- Ministry of Public Health
- Start
- Sep 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in abnormal uterine bleeding (AUB), infertility, recurrent pregnancy loss (RPL) and 2 more comparing Misoprostol Group with Placebo Group (2 arms). Primary endpoint: initial cervical diameter at 1 year. Started Sep 2018; status: completed.
02
Drugs
misoprostol
03
Conditions
abnormal uterine bleeding (AUB)infertilityrecurrent pregnancy loss (RPL)chronic pelvic pain (CPP)postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT03638856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03638856.